接着バリア市場-世界の産業規模、シェア、動向、機会、および予測、2018～2028年、製品別、製剤別、用途別、地域別、競合

接着バリアの世界市場は、2022年に7億2,489万米ドルと評価され、2028年までの年間平均成長率（CAGR）は5.54％と予測され、予測期間中に力強い成長が見込まれており、2028年には10億290万米ドルに達すると予測されています。

接着バリアは、組織や臓器間の接着形成を防ぐために外科手術で使用される医療機器です。接着とは、手術後、損傷後、炎症後にできる瘢痕組織の帯を指します。これらの接着は、本来つながっていない組織同士を結合させる可能性があり、合併症や患者さんの不快感につながる可能性があります。

接着バリアは、手術後の治癒過程において、組織間に物理的なバリアを確立するために細心の注意を払って設計されています。このバリアは組織の接着を阻止する役割を果たし、接着が起こらなければ、疼痛、腸閉塞、不妊症、その他の医学的問題などの合併症を引き起こす可能性があります。通常、接着バリアは人体内で安全に使用できる生体適合性材料から作られています。接着バリアを採用する第一の目的は、術後の接着に起因する合併症のリスクを減らすことによって、患者の転帰を向上させることです。これにより、入院期間の短縮、回復時間の短縮、合併症による再入院の減少に貢献します。

病院や医療プロバイダーは、術後の合併症を最小限に抑え、患者の満足度を高め、追加的な医療費を軽減することにますます力を注いでいます。接着バリアは、こうした目的を達成する上で極めて重要な役割を果たしています。

主な市場促進要因

• 1.世界の高齢化人口の増加：世界人口の高齢化が進むにつれ、外科的介入を必要とする加齢に関連した病状の有病率が高まっています。高齢者は手術を受ける可能性が高く、加齢に伴う組織治癒メカニズムの変化により、術後接着のリスクが高くなることが多いです。接着防止バリアは、高齢患者におけるこれらのリスクを軽減し、合併症を予防するために極めて重要です。
• 2.接着関連合併症の増加：接着関連合併症は、体内での接着の形成により生じる。これらの合併症は、腹痛、腸閉塞、不妊症、運動制限など様々な健康問題を引き起こす可能性があります。接着予防は不可欠であり、接着防止バリアは外科手術に不可欠です。
• 3.低侵襲手術に対する需要の高まり：低侵襲手術手技は、従来の開腹手術に比べて切開創が小さいです。接着防止バリアは、患者の回復を早める一方で接着を防ぐため、こうした手術に不可欠です。低侵襲的アプローチへの嗜好の高まりが、適合する接着バリアの需要を牽引しています。

主な市場課題

• 1.有効性と寿命：接着防止における接着バリアの有効性を確保し、その性能を長期にわたって維持することは非常に重要です。患者の反応のばらつき、手術手技の複雑さ、バリア設置の課題などが、その有効性に影響を及ぼす可能性があります。
• 2.有害事象と副作用：接着防止バリアは、感染、炎症、アレルギー反応などの副作用や合併症を引き起こす可能性があります。患者固有の病歴や遺伝的背景は、接着バリアに対する反応のばらつきの一因となります。

主な市場動向

• 1.材料科学の進歩：材料科学の絶え間ない発展により、生体組織と調和的に相互作用し、接着バリアの生体適合性、有効性、耐久性を保証する高度な材料が生み出されています。これらの材料は、特定の外科手術のニーズに合わせて特性を調整したり、分解を制御したり、ドラッグデリバリー機能まで提供することができます。
• 2.セグメント別洞察

a.製品別洞察：a.製品洞察：合成接着バリアは、生体適合性と有効性を高める合成材料の進歩により、市場をリードしています。合成接着バリアは汎用性を持たせることができるため、幅広い外科手術に適しています。

b.製剤別洞察：フィルムとメッシュの接着バリアは、治癒中の組織を物理的に分離する効果があるため、市場を独占しています。その使いやすさと汎用性により、外科医の採用率が高くなっています。

c.用途別洞察：心臓血管外科手術では、血管や心臓のようなデリケートな構造物の周囲の合併症を防ぐために接着バリアを必要とすることが多いため、市場で大きなシェアを占めています。

地域別洞察：北米は、高度な医療インフラ、手術件数の多さ、強固な研究開発能力、厳格な規制環境などにより、世界の接着バリア市場で支配的な地位を確立しています。北米の主要市場参入企業には、Johnson & Johnson (J&J)、Baxter International、Integra Lifesciences (ILS)、FzioMedなどがあります。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 接着バリアの世界市場展望

• 市場規模・予測
  • 金額・数量別
• 市場シェアと予測
  • 製品別（合成接着バリア（ヒアルロン酸、再生セルロース、ポリエチレングリコール、その他）、天然接着バリア（コラーゲン&タンパク質、フィブリン））
  • 剤型別（フィルム・メッシュ、ゲル、液体）
  • 用途別（婦人科手術、腹部一般手術、整形外科手術、心臓血管手術、神経外科手術、泌尿器科手術、その他）
  • 企業別（2022年）
  • 地域別
• 市場マップ

第6章 北米の接着バリア市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 製剤別
  • 用途別
• 北米：国別分析
  • 米国接着バリア
  • メキシコ
  • カナダ

第7章 欧州の接着バリア市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 製剤別
  • 用途別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の接着バリア市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 製剤別
  • 用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の接着バリア市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 製剤別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの接着バリア市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 製剤別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦の展望

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 製品上市
• 合併と買収

第13章 PESTLE分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Vendor Landscape
• Medtronic Plc
• Johnson & Johnson SA
• Sanofi SA
• Baxter International Inc.,
• Becton Dickinson and Company
• Integra LifeSciences Holdings Corporation
• Atrium Medical Corporation
• FzioMed Inc.
• Mast Biosurgery AG

第16章 戦略的提言

The Global Adhesion Barrier Market, valued at USD 724.89 Million in 2022, is poised for robust growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 5.54% through 2028 and is expected to reach USD 1002.90 Million in 2028. An adhesion barrier is a medical device employed in surgical procedures to prevent the formation of adhesions between tissues and organs. Adhesions refer to bands of scar tissue that can develop post-surgery, injury, or inflammation. These adhesions have the potential to bind together tissues that are not naturally connected, potentially leading to complications and discomfort for the patient.

Adhesion barriers are meticulously designed to establish a physical barrier between tissues during the healing process following surgery. This barrier serves to thwart the adhesion of tissues, which can otherwise result in complications such as pain, bowel obstruction, infertility, and other medical issues. Typically, adhesion barriers are crafted from biocompatible materials that are safe for use within the human body. The primary objective of employing adhesion barriers is to enhance patient outcomes by reducing the risk of complications stemming from post-operative adhesions. They contribute to shorter hospital stays, faster recovery times, and a reduction in readmissions due to complications.

The trend towards minimally invasive surgical procedures necessitates adhesion barriers that can be applied through smaller incisions while maintaining their efficacy in preventing adhesions. As minimally invasive techniques gain popularity, the demand for compatible adhesion barriers continues to surge. Furthermore, the global aging population significantly drives surgical procedures, especially those associated with age-related conditions. This demographic trend further fuels the demand for adhesion barriers.

Hospitals and healthcare providers are increasingly dedicated to minimizing post-operative complications, enhancing patient satisfaction, and mitigating additional healthcare costs. Adhesion barriers play a pivotal role in achieving these objectives.

Key Market Drivers

• 1. Growing Global Aging Population: As the world's population continues to age, there is a heightened prevalence of age-related medical conditions that necessitate surgical interventions. Older individuals are more likely to undergo surgeries, which often involve higher risks of post-operative adhesions due to age-related changes in tissue healing mechanisms. Adhesion barriers are crucial for reducing these risks and preventing complications in older patients.

• 2. Increasing Adhesion-Related Complications: Adhesion-related complications arise due to the formation of adhesions within the body. These complications can lead to various health problems, including abdominal pain, bowel obstruction, infertility, and movement restrictions. Adhesion prevention is essential, making adhesion barriers indispensable in surgical procedures.

• 3. Rising Demand for Minimally Invasive Procedures: Minimally invasive surgical techniques involve smaller incisions compared to traditional open surgery. Adhesion barriers are essential for these procedures to prevent adhesions while facilitating quicker patient recovery. The growing preference for minimally invasive approaches drives the demand for compatible adhesion barriers.

Key Market Challenges

• 1. Efficacy and Longevity: Ensuring the effectiveness of adhesion barriers in preventing adhesions and maintaining their performance over time is critical. Variability in patient responses, complexity of surgical procedures, and barrier placement challenges can influence their efficacy.

• 2. Adverse Events and Side Effects: Adhesion barriers can potentially lead to adverse reactions or complications, including infections, inflammation, and allergic responses. Patients' unique medical histories and genetic backgrounds contribute to variations in their reactions to adhesion barriers.

Key Market Trends

• 1. Advancements in Material Science: Continuous developments in material science lead to the creation of advanced materials that interact harmoniously with the body's tissues, ensuring biocompatibility, effectiveness, and durability of adhesion barriers. These materials can offer tailored properties for specific surgical needs, controlled degradation, and even drug delivery capabilities.

• 2. Segmental Insights:

a. Product Insights: Synthetic adhesion barriers lead the market due to ongoing advancements in synthetic materials, enhancing biocompatibility and effectiveness. Synthetic adhesion barriers can be engineered for versatility, making them suitable for a wide range of surgical procedures.

b. Formulation Insights: Film and mesh adhesion barriers dominate the market due to their effectiveness in physically separating tissues during healing. Their ease of use and versatility contribute to higher adoption rates among surgeons.

c. Application Insights: Cardiovascular surgeries claim a significant share of the market, as they often require adhesion barriers to prevent complications around delicate structures like blood vessels and the heart.

Regional Insights: North America has established itself as the dominant player in the global adhesion barrier market, owing to advanced healthcare infrastructure, high surgical procedure volumes, robust research and development capabilities, and a stringent regulatory environment. Key market players in North America include Johnson & Johnson (J&J), Baxter International, Integra Lifesciences (ILS), and FzioMed.

Key Market Players

• Vendor Landscape
• Medtronic Plc
• Johnson & Johnson SA
• Sanofi SA
• Baxter International Inc.,
• Becton Dickinson and Company
• Integra LifeSciences Holdings Corporation
• Atrium Medical Corporation
• FzioMed Inc.
• Mast Biosurgery AG

Report Scope:

In this report, the Global Adhesion Barrier Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Adhesion Barrier Market, By Product:

• Synthetic Adhesion Barriers
• Hyaluronic acid
• Regenerated cellulose
• Polyethylene glycol
• Others
• Natural Adhesion Barriers
• Collagen & Protein
• Fibrin

Adhesion Barrier Market, By Formulation:

• Film/Mesh
• Gel
• Liquid

Adhesion Barrier Market, By Application:

• Gynecological surgeries
• Abdominal general surgeries
• Orthopedic surgeries
• Cardiovascular surgeries
• Neurological surgeries
• Urological surgeries
• others

Global Adhesion Barrier Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Adhesion Barrier Market.

Available Customizations:

• Global Adhesion Barrier Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Adhesion Barrier Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value & Volume
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Synthetic Adhesion Barriers (Hyaluronic acid, Regenerated cellulose, Polyethylene glycol, others), Natural Adhesion Barrier (Collagen & Protein, Fibrin))
  • 5.2.2. By Formulation (Film/Mesh, Gel, Liquid)
  • 5.2.3. By Application (Gynecological surgeries, Abdominal general surgeries, Orthopedic surgeries, Cardiovascular surgeries, Neurological surgeries, Urological surgeries, others)
  • 5.2.4. By Company (2022)
  • 5.2.5. By Region
• 5.3. Market Map

6. North Adhesion Barrier Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Formulation
  • 6.2.3. By Application
• 6.3. North America: Country Analysis
  • 6.3.1. United States Adhesion Barrier Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Formulation
      • 6.3.1.2.3. By Application
  • 6.3.2. Mexico Adhesion Barrier Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Formulation
      • 6.3.2.2.3. By Application
  • 6.3.3. Canada Adhesion Barrier Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Formulation
      • 6.3.3.2.3. By Application

7. Europe Adhesion Barrier Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Formulation
  • 7.2.3. By Application
• 7.3. Europe: Country Analysis
  • 7.3.1. France Adhesion Barrier Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Formulation
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Adhesion Barrier Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Formulation
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Adhesion Barrier Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Formulation
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Adhesion Barrier Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Formulation
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Adhesion Barrier Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Formulation
      • 7.3.5.2.3. By Application

8. Asia-Pacific Adhesion Barrier Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Formulation
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Adhesion Barrier Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Formulation
      • 8.3.1.2.3. By Application
  • 8.3.2. India Adhesion Barrier Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Formulation
      • 8.3.2.2.3. By Application
  • 8.3.3. South Korea Adhesion Barrier Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Formulation
      • 8.3.3.2.3. By Application
  • 8.3.4. Japan Adhesion Barrier Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Formulation
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Adhesion Barrier Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Formulation
      • 8.3.5.2.3. By Application

9. South America Adhesion Barrier Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Formulation
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Adhesion Barrier Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Formulation
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Adhesion Barrier Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Formulation
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Adhesion Barrier Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Formulation
      • 9.3.3.2.3. By Application

10. Middle East and Africa Adhesion Barrier Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Formulation
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Adhesion Barrier Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Formulation
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Adhesion Barrier Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Formulation
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Adhesion Barrier Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Formulation
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Company Snapshot
• 15.3. Products & Services
• 15.4. Financials (In case of listed companies)
• 15.5. Recent Developments
• 15.6. SWOT Analysis
  • 15.6.1. Vendor Landscape
  • 15.6.2. Medtronic Plc
  • 15.6.3. Johnson & Johnson SA
  • 15.6.4. Sanofi SA
  • 15.6.5. Baxter International Inc.,
  • 15.6.6. Becton Dickinson and Company
  • 15.6.7. Integra LifeSciences Holdings Corporation
  • 15.6.8. Atrium Medical Corporation
  • 15.6.9. FzioMed Inc.
  • 15.6.10. Mast Biosurgery AG

16. Strategic Recommendations